Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 67 out of 100. How common it is

Topic: Risk, prevention and care in population studies

Objective To estimate the incidence and prevalence of frontotemporal dementia and its clinical variants in the overall population and age subgroups. Results From 1854 screened articles, 32 eligible population-based studies were identified. Conclusions and relevance In this systematic review and meta-analysis, estimates indicate that FTD is comparable in frequency to dementia with Lewy bodies and occurs at higher rates than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis. These results provide a foundation for future research and public health strategy, especially for underrepresented populations, to better comprehend the global burden of FTD. Our findings provide robust pooled estimates of the incidence and prevalence of FTD and its subtypes, offering a foundation for future research and public health planning.

Key findings

Why it matters

This review pooled 32 population-based studies to estimate how often frontotemporal dementia occurs. It found that FTD is comparable in frequency to dementia with Lewy bodies and more common than progressive supranuclear palsy, corticobasal syndrome, and amyotrophic lateral sclerosis, which the authors say provides a foundation for future research and public health planning.

Study details

Limitations

Very high heterogeneity (I² above 90%) driven by differing case definitions and denominators; few studies outside Europe and North America; likely under-ascertainment of FTD in population studies.

How this study scored 67/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 12 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 3 of 5; Impact for its field and year 5 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 4 of 4; Institution's track record 2 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 66 of the 98 points it could be judged on, which is 67 of 100. Total 67 of 100.66 of the 98 points we could judge = 67 of 100

Published in a leading specialty journal, and it is a meta-analysis pooling many studies. Scored zero for sample size and studied in people because the record does not state it. We have no data on free to read, so that was left out: it earned 66 of the 98 points we could judge it on, which is 67 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (JAMA Neurology)
Journal's citation record 2 / 4 JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 A review of other studies — randomisation is not credited here
Times cited 3 / 7 Cited 36 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 12.0 citations a year over 3 year(s) since 2025
Impact for its field and year 5 / 6 Cited 21.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 2 other studies in this library
Still being cited 2 / 4 Cited 33 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Giancarlo Logroscino: h-index 126 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Cambridge: institution h-index 1,973 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40920400)
Free to read — / 2 Access not recorded — left out of this score
Points 66 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 66 of the 98 points we could judge it on is 67 out of 100.
Total 67 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Urso, D., Giannoni-Luza, S., Brayne, C., Ray, N., & Logroscino, G. (2025). Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2025.3307

Vancouver

Urso D, Giannoni-Luza S, Brayne C, Ray N, Logroscino G. Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis. JAMA Neurology. 2025. doi:10.1001/jamaneurol.2025.3307. PMID: 40920400.

BibTeX

@article{urso2025-40920400,
  author  = {Urso, D. and Giannoni-Luza, S. and Brayne, C. and Ray, N. and Logroscino, G.},
  title   = {{Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3307},
  pmid    = {40920400},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3307}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Later studies that cite this one

2 studies in the alzhub library list this one in their references.

Related studies in How common it is

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on How common it is

See all studies in How common it is →